Company
Menlo Park
Every investor coverage indicates participated in a round ChronicleBio raised.
Companies ChronicleBio acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Rishi Reddy | Executive Chairman | Forbes Australia |
| Rohit Gupta | CEO | Forbes Australia |
Stories naming ChronicleBio. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Profile of Fidji Simo, who left OpenAI to cofound ChronicleBio, which has raised $20 million to use AI and biological data to subtype chronic illnesses like POTS and long COVID and rescue shelved drugs.